SEC Filing Summary for Kihara James

Kihara James, the Principal Accounting Officer of ACADIA PHARMACEUTICALS INC, reported a sale of 11,421 shares of common stock on June 26, 2026. The sale was executed as part of a Rule 10b5-1 Plan. The shares were sold at prices ranging from $25.88 to $26.265, with an average price of $26.0846. Following this transaction, James holds 13,088 shares of common stock. This filing is a Form 4, indicating a change in beneficial ownership.